Search Results - "Kieszkowski, Przemysław"
-
1
Activation contact system (ACS) and tissue factor (TF) in human amniotic fluid: Measurements of ACS components and TF, and some implications on the pathophysiology of amniotic fluid embolism
Published in Thrombosis research (01-04-2015)“…Abstract Background/Aim It is believed that the amniotic fluid-derived TF, in the case of amniotic fluid embolism(AFE), contributes to acute disseminated…”
Get full text
Journal Article -
2
Variances in the Level of COX-2 and iNOS in Different Grades of Endometrial Cancer
Published in Current pharmaceutical biotechnology (01-01-2020)“…Many experimental studies have demonstrated the importance of COX-2 in the tumor angiogenesis. Inducible iNOS is responsible for a high and stable level of…”
Get more information
Journal Article -
3
Assessment of the Usefulness of the SEMA5A Concentration Profile Changes as a Molecular Marker in Endometrial Cancer
Published in Current pharmaceutical biotechnology (01-01-2020)“…Semaphorin 5A (SEMA5A) functions not only in the nervous system but also in cancer transformation where its role has not yet been sufficiently studied and…”
Get more information
Journal Article -
4
Assessment of Expression of Homeobox A5 in Endometrial Cancer on the mRNA and Protein Level
Published in Current pharmaceutical biotechnology (01-01-2020)“…Endometrial cancer is one of the most common gynecological cancer in the developed countries and occurs mainly in postmenopausal women. Angiogenesis is…”
Get more information
Journal Article -
5
Expression of Semaphorin 3B (SEMA3B) in Various Grades of Endometrial Cancer
Published in Medical science monitor (20-06-2019)“…BACKGROUND SEMA3B is known as an inhibitor of angiogenesis and cell proliferation. During carcinogenesis, the loss of SEMA3B function is observed, which…”
Get full text
Journal Article -
6
Changes in Expression Pattern of SEMA3F Depending on Endometrial Cancer Grade - Pilot Study
Published in Current pharmaceutical biotechnology (01-01-2019)“…In the course of neoplastic diseases, a reduction in SEMA3F expression is observed, which translates into an increase in the proliferative and proangiogenic…”
Get more information
Journal Article -
7
Differences in the Expression Pattern of mRNA Protein SEMA3F in Endometrial Cancer in vitro under Cisplatin Treatment
Published in Current pharmaceutical biotechnology (2020)“…Semaphorin 3F (SEMA3F) plays a substantial role in carcinogenesis, because of its role in inducing angiogenesis, and creating a microenvironment for the…”
Get more information
Journal Article